LeadIQ logo
Learn more at LeadIQ.com

Insights

Clinical stage Noveome is a clinical-stage biotherapeutics company with a focus on regenerative repair of damaged tissues and a broad, cell-free secretome platform. Sales opportunities exist in partnering with pharma/biotech firms seeking next-generation biologics for tissue regeneration, wound healing, and inflammatory injury indications.

Funding and growth Recent Series E financing totaling 51M in 2025 underscores strong investor confidence and near-term clinical milestones. This suggests capacity for expanded collaborations, co-development deals, and potential licensing opportunities to accelerate trials and broaden the product footprint.

Strategic collaborations Active history of collaborations and licensing, including the SipNose device partnership and engagements with major research centers. This indicates a readiness to engage in strategic alliances, distribution agreements, and joint development for device-compatible or combination therapies.

Technology and IP potential Noveome’s platform delivers a complex biomolecule mix with potential broad applicability across conditions and injuries. There are opportunities to position as a platform-enabled partner for multi-indication programs, modular collaborations, and contract research or manufacturing services for biologics.

Geographic focus & market fit Headquartered in the Pittsburgh region with emphasis on Allegheny County biotherapeutic leadership. This offers regional sales opportunities with local academic collaborations, contract development/manufacturing, and government or regional funding-backed partnerships, while also enabling scalable regional partnerships to national buyers.

Similar companies to Noveome Biotherapeutics, Inc.

Noveome Biotherapeutics, Inc. Tech Stack

Noveome Biotherapeutics, Inc. uses 8 technology products and services including WordPress, Shopify, Google Cloud, and more. Explore Noveome Biotherapeutics, Inc.'s tech stack below.

Media & News

Noveome Biotherapeutics, Inc.'s Email Address Formats

Noveome Biotherapeutics, Inc. uses at least 2 email formats:
Noveome Biotherapeutics, Inc. Email FormatsExamplePercentage
FLast@noveome.comJDoe@noveome.com
96%
FirstLast@noveome.comJohnDoe@noveome.com
4%

Frequently Asked Questions

What is Noveome Biotherapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Noveome Biotherapeutics, Inc.'s main corporate office by phone at
+1-412-402-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Noveome Biotherapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc.'s official website is noveome.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Noveome Biotherapeutics, Inc. generate?

Minus sign iconPlus sign icon As of August 2026, Noveome Biotherapeutics, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Noveome Biotherapeutics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Noveome Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of August 2026, Noveome Biotherapeutics, Inc. has approximately 31 employees across 1 continents, including North America. Key team members include Chief Operating Officer: K. M., Director Project Management: M. C. and Director Of Cell Therapy And Research: R. B. Explore Noveome Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does Noveome Biotherapeutics, Inc. belong to?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Noveome Biotherapeutics, Inc. use?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc.'s tech stack includes WordPress, Shopify, Google Cloud, Constant Contact, Office 365, WP Engine, Google Tag Manager and Adobe Creative Suite.

What is Noveome Biotherapeutics, Inc.'s email format?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc.'s email format typically follows the pattern of FLast@noveome.com. Find more Noveome Biotherapeutics, Inc. email formats with LeadIQ.

How much funding has Noveome Biotherapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of August 2026, Noveome Biotherapeutics, Inc. has raised $74M in funding. The last funding round occurred on Sep 17, 2023 for $51M.

When was Noveome Biotherapeutics, Inc. founded?

Minus sign iconPlus sign iconNoveome Biotherapeutics, Inc. was founded in 2000.
Noveome Biotherapeutics, Inc. logo

Noveome Biotherapeutics, Inc.

Biotechnology ResearchPennsylvania, United States11-50 Employees

Noveome Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on regenerative therapies that aim to restore cellular integrity in inflamed or damaged tissues. Its approach centers on a complex mixture of biomolecules rather than a single molecule, with potential applicability across a broad range of conditions and injuries. The company collaborates with major research centers to advance its therapeutic programs and is based in the Fox Chapel area of Pittsburgh, Pennsylvania, in Allegheny County.

In November 2022, Noveome appointed two new directors to its board, reflecting governance updates as it advances its programs. The organization operates as a clinical-stage biotechnology company and collaborates with research institutions to advance its pipeline focused on tissue repair.

Section iconCompany Overview

Phone number
+1-412-402-****
Website
noveome.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $74M

    Noveome Biotherapeutics, Inc. has raised a total of $74M of funding over 6 rounds. Their latest funding round was raised on Sep 17, 2023 in the amount of $51M as a Series E.

  • $10M - $25M

    Noveome Biotherapeutics, Inc.'s revenue is estimated to be in the range of $10M - $25M

Company Leadership

  • Chief Operating Officer at Noveome Biotherapeutics, Inc.
    K. M.
    Chief Operating Officer
    Mobile Phone
  • Director Project Management at Noveome Biotherapeutics, Inc.
    M. C.
    Director Project Management
    Mobile Phone
  • Director Of Cell Therapy And Research at Noveome Biotherapeutics, Inc.
    R. B.
    Director Of Cell Therapy And Research
    Mobile Phone
  • Director, Regulatory Affairs And Quality at Noveome Biotherapeutics, Inc.
    T. M.
    Director, Regulatory Affairs And Quality
    Mobile Phone
  • Quality Assurance Manager at Noveome Biotherapeutics, Inc.
    A. H.
    Quality Assurance Manager
    Mobile Phone

Employee Directory

  • Board Member at Noveome Biotherapeutics, Inc.
    E. K.
    Board Member
    Mobile Phone
  • Quality Control Analyst Ii at Noveome Biotherapeutics, Inc.
    G. B.
    Quality Control Analyst Ii
    Mobile Phone
  • Quality Control Supervisor at Noveome Biotherapeutics, Inc.
    A. M.
    Quality Control Supervisor
    Mobile Phone
  • Clinical Trial Assistant at Noveome Biotherapeutics, Inc.
    B. M.
    Clinical Trial Assistant
    Mobile Phone
  • Quality Control Analyst at Noveome Biotherapeutics, Inc.
    J. C.
    Quality Control Analyst
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.